I am sure it will work in the long run to, but my concern is if people are expecting it to work in a sub therapeutic dose then they will be disappointed and sell if it doesn't, without understanding that any reduced viral load from this first dose would be a bonus but not the aim ... safety is.
this dose is 1/100th of the highest dose to be examined in the trial ... so if it does show a reduced viral load then that will be AMAZING
Add to My Watchlist
What is My Watchlist?